Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
AnaptysBio, Inc.
Business Segments
Business Segments
Net Income Loss
Net Income Loss
AnaptysBio, Inc.
·
Business Segments
·
2 segments
·
Rolls up to
Net Income
Breakdown
Segments
Biopharma Company
View metric
Royalty Management Company
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Biopharma Company
-$50.48M
Royalty Management Company
-$2.4M
Total
-$52.88M